PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare

Completed

• Conditions: PrEP Precriptions for Reproductive Aged Women

• Registration Number: NCT07209722
• Lead Sponsor: University of Alabama at Birmingham

Brief Summary

The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-09-22
• Primary Completion: 2024-08-26
• Study Completion: 2024-08-26
• Status Verified: 2025-09
• Study First Submitted: 2025-09-29
• Study First Submitted QC: 2025-09-29
• Last Update Submitted: 2025-09-29
• Study First Posted: 2025-10-07
• Last Update Posted: 2025-10-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 1135

Inclusion Criteria

• Patient of UAB GYN clinic

Exclusion Criteria

• Not a patient of UAB GYN clinic

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PrEP prescriptions	8 months	1\. Visits per period (of intervention) with number of PrEP prescriptions

Trial Locations

Locations (1)

University of Alabama at Birmingham; 🇺🇸 Birmingham, Alabama, United States